The EBMT is a non-profit organization established in 1974. For more than 47 years, has developed into the leading scientific society in Europe in the cutting-edge field of stem cell transplantation and cellular therapy.
The EBMT has offices based in Barcelona, Leiden and Paris, and currently has over 140 employees. If you are looking to join non-profit organisation where you can make a difference, apply to one of the open staff or society career opportunities posted below:
EBMT Staff Vacancies
Are you looking for a job where you can make a difference and work in a non-profit?
Would you like to be a part of an international organisation on the cutting edge of science?
EBMT Society Vacancies
Our society aims to be the connection between patients, researchers and other stakeholders to anticipate the future of cellular and stem cell-based therapies. If you're looking for a position within an EBMT Working Party, EBMT Committee or the EBMT Nurses Group, see below:
Trainee Committee Member
The EBMT Trainee Committee aims to be a bridge between early-career haematologists across the world and opportunities in stem cell transplantation and cellular therapy. Together with the EBMT and its Working Parties, the Trainee Committee nurtures education, research, and innovation in this exciting and evolving field.
We welcome diverse voices and fresh perspectives. If you are an early-career professional or aspiring specialist in haematology, transplantation, or cellular therapy—whether a medical student, researcher, clinician, nurse, bioinformatician, or physician-scientist—we would love to hear from you.
You may be a great fit if you are:
● Eager to contribute ideas, skills, or tools that amplify our impact
● Passionate about creating an inclusive and transparent space for growth
● Keen to build bridges across borders and disciplines
● Willing to dedicate an average of 5 hours per month to meaningful projects, including virtual meetings every 1–2 months
If you are interested in joining, please complete the application form by 15 August 2025.